LabWare is a Key Partner in Helping Laboratories Respond to COVID-19
Feb 16 2021
LabWare has been actively working with public and private sector organisations worldwide to apply their considerable know-how and advanced technology to implement COVID-19 testing capability and other workflow and operational efficiency enhancements. This is helping to increase laboratory testing capacity to meet unprecedented public health testing demands.
LabWare’s efforts include assisting in the efforts to expand the NHS COVID-19 testing operations in the UK; providing laboratory management software for new COVID-19 laboratories in Brazil; assisting US public health customers to implement new COVID-19 tests and communications protocols for reporting to the CDC; adding/expanding COVID-19 testing capabilities throughout their public health customer base in sub-Saharan Africa, and assisting Canadian public health customers with performance improvements to handle the surge of COVID-19 tests.
LabWare are developing solutions, including the Portable Disease Surveillance Lab (PDSL) that leverage LabWare's Mobile technology to streamline the COVID-19 patient registration and sample collection process as part of field-based specimen collection and COVID-19 testing operations. These solutions are being deployed at the company’s state public health lab customers.
More information online
In this Edition Articles - Applications of Newly Developed 2.7 μm Porous Graphitic Carbon Particles in U/HPLC - Improve sensitivity and decrease matrix effects in pesticide residue analysis...
View all digital editions
Oct 20 2021 Online
Oct 26 2021 London, UK
Oct 26 2021 Moscow, Russia
Oct 27 2021 Virtual event
Oct 31 2021 Philadelphia, PA, USA